{"id":"W2945798005","doi":"10.1016/j.trci.2019.04.001","title":"Enrichment factors for clinical trials in mild‐to‐moderate Alzheimer's disease","year":2019,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Translational Research & Clinical Interventions","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Allergan; Genentech; Grifols; H. Lundbeck A/S; University of Oxford; Sunovion; National Institute of General Medical Sciences; Teva Pharmaceutical Industries; Biogen; American College of Radiology; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Acadia University; Cognoptix; Pfizer; AbbVie; Merck; Alzheimer's Association","keywords":"Clinical trial; Disease; Alzheimer's disease; Medicine; Internal medicine; Gerontology; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3362387,0.002195629,0.005318203,0.002406512,0.001341927,0.004260263,0.001816761,0.003349674,0.0113091],"category_scores_gemma":[0.5240532,0.001486551,0.009378248,0.002626229,0.003183968,0.004599065,0.003152782,0.003860704,0.0009143322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002822809,"about_ca_system_score_gemma":0.004765884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007257675,"about_ca_topic_score_gemma":0.0008567672,"domain_scores_codex":[0.3926439,0.5598138,0.0231496,0.009444322,0.01274706,0.00220129],"domain_scores_gemma":[0.3644658,0.5746204,0.02660523,0.0233655,0.008524575,0.002418516],"domain_codex":"methods","domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.193051,0.001840142,0.09726043,0.04435792,0.1137745,0.000586489,0.001866507,0.03646465,0.004257484,0.06029208,0.02335825,0.4228908],"study_design_scores_gemma":[0.1190671,0.04460381,0.119308,0.02131993,0.09170336,0.001118835,0.0007138749,0.2067044,0.01056915,0.2632584,0.1208328,0.0008003072],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.1973369,0.06990063,0.5754575,0.02482184,0.005671867,0.08927961,0.006090078,0.003540226,0.02790122],"genre_scores_gemma":[0.7855305,0.001690283,0.1610815,0.002503409,0.0006732194,0.04668536,0.0005864134,0.0001254482,0.001123893],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.3362387,"threshold_uncertainty_score":0.8185359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6245633221272933,"score_gpt":0.6228928141282654,"score_spread":0.001670507999027904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}